GSK PLC ADR (GSK) Social Stream
GSK PLC (GSK) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering GSK PLC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 8 | $52.5 | $41.5 | $47.75 | $34.83 | 37.09% |
| 2022-01-03 | 8 | $51 | $41.5 | $47.375 | $34.83 | 36.02% |
| 2022-01-17 | 7 | $51 | $44.2 | $48.733 | $34.83 | 39.92% |
| 2022-02-02 | 7 | $52.5 | $44.2 | $49.233 | $34.83 | 41.35% |
| 2022-02-14 | 7 | $52.5 | $46.3 | $49.933 | $34.83 | 43.36% |
| 2022-03-14 | 7 | $51.5 | $45.6 | $49.366 | $34.83 | 41.73% |
| 2022-04-05 | 7 | $55 | $45.6 | $50.533 | $34.83 | 45.08% |
| 2022-04-19 | 7 | $55 | $45.7 | $50.566 | $34.83 | 45.18% |
| 2022-04-21 | 7 | $55 | $44.5 | $50.166 | $34.83 | 44.03% |
| 2022-04-27 | 7 | $55 | $45.9 | $50.633 | $34.83 | 45.37% |
| 2022-05-31 | 6 | $52.5 | $45.9 | $49.8 | $34.83 | 42.98% |
| 2022-06-07 | 7 | $52.5 | $45.9 | $49.8 | $34.83 | 42.98% |
| 2022-06-16 | 7 | $51 | $45.9 | $49.133 | $34.83 | 41.07% |
| 2022-07-26 | 7 | $63.125 | $44.4 | $52.841 | $34.83 | 51.71% |
| 2022-08-13 | 7 | $63.125 | $43.5 | $52.541 | $34.83 | 50.85% |
| 2022-08-24 | 7 | $63.125 | $36 | $50.041 | $34.83 | 43.67% |
| 2022-09-19 | 7 | $51 | $34 | $40.333 | $34.83 | 15.8% |
| 2022-10-21 | 7 | $51 | $33 | $40 | $34.83 | 14.84% |
| 2022-11-01 | 7 | $51 | $33 | $40.666 | $34.83 | 16.76% |
| 2022-11-23 | 7 | $51 | $33 | $40.666 | $34.83 | 16.76% |
| 2022-12-04 | 7 | $51 | $33 | $40.666 | $34.83 | 16.76% |
| 2022-12-05 | 7 | $51 | $33 | $39.833 | $34.83 | 14.36% |
| 2022-12-07 | 7 | $51 | $33 | $40.066 | $34.83 | 15.03% |
| 2023-02-01 | 7 | $51 | $36.2 | $41.733 | $34.83 | 19.82% |
The Trend in the Analyst Price Target
GSK's average price target has moved down $4.36 over the prior 28 months.
GSK reports an average of 19.44% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-16 | 7 | 51.000 | 45.9 | 49.133 | 41.64 | 17.99% |
| 2022-08-13 | 7 | 63.125 | 43.5 | 52.541 | 36.03 | 45.83% |
| 2022-09-12 | 7 | 51.000 | 34.0 | 40.333 | 32.45 | 24.29% |
| 2022-11-01 | 7 | 51.000 | 33.0 | 40.666 | 33.46 | 21.54% |
| 2022-12-04 | 7 | 51.000 | 33.0 | 40.666 | 35.35 | 15.04% |
GSK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.71 | 0 | 0 | 4 | 2 | 2 | 7 |
The Trend in the Broker Recommendations
GSK's average broker recommendation rating worsened by 1.04 over the prior 37 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how GSK PLC fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is higher than 305.7% of that group.
- In terms of how GSK PLC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -316.33% of that group.
- In the context of Pharmaceutical Products stocks, GSK PLC's upside potential (average analyst target price relative to current price) is higher than 598.68% of them.
- In terms of how GSK PLC fares relative to stocks in the large market cap category, note that its average analyst price target is greater than 637.39% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to GSK PLC are GRFS, SNY, and GLPG.
View All Top Stocks by Price Target
Is GSK a Buy, Hold or Sell? See the POWR Ratings now!